The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leishmaniasis, Visceral

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leishmaniasis, Visceral


High impact information on Leishmaniasis, Visceral


Chemical compound and disease context of Leishmaniasis, Visceral


Biological context of Leishmaniasis, Visceral


Anatomical context of Leishmaniasis, Visceral


Gene context of Leishmaniasis, Visceral


Analytical, diagnostic and therapeutic context of Leishmaniasis, Visceral


  1. Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Charest, H., Matlashewski, G. Mol. Cell. Biol. (1994) [Pubmed]
  2. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Zhang, W.W., Matlashewski, G. Mol. Microbiol. (2001) [Pubmed]
  3. Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in Leishmania donovani-Infected Macrophages. Mookerjee Basu, J., Mookerjee, A., Sen, P., Bhaumik, S., Sen, P., Banerjee, S., Naskar, K., Choudhuri, S.K., Saha, B., Raha, S., Roy, S. Antimicrob. Agents Chemother. (2006) [Pubmed]
  4. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Berman, J.D., Ksionski, G., Chapman, W.L., Waits, V.B., Hanson, W.L. Antimicrob. Agents Chemother. (1992) [Pubmed]
  5. Use of purified parasite proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis. Jaffe, C.L., Zalis, M. J. Infect. Dis. (1988) [Pubmed]
  6. Miltefosine for visceral leishmaniasis. Eibl, H. N. Engl. J. Med. (2000) [Pubmed]
  7. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Ato, M., Stäger, S., Engwerda, C.R., Kaye, P.M. Nat. Immunol. (2002) [Pubmed]
  8. Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. Taylor, A.P., Murray, H.W. J. Exp. Med. (1997) [Pubmed]
  9. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. Powrie, F., Correa-Oliveira, R., Mauze, S., Coffman, R.L. J. Exp. Med. (1994) [Pubmed]
  10. Potential role for interleukin-10 in the immunosuppression associated with kala azar. Holaday, B.J., Pompeu, M.M., Jeronimo, S., Texeira, M.J., Sousa, A.d.e. .A., Vasconcelos, A.W., Pearson, R.D., Abrams, J.S., Locksley, R.M. J. Clin. Invest. (1993) [Pubmed]
  11. Amphotericin B for second-line treatment of Indian kala-azar. Mishra, M., Singh, M.P., Choudhury, D., Singh, V.P., Khan, A.B. Lancet (1991) [Pubmed]
  12. Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Anabwani, G.M., Ngira, J.A., Dimiti, G., Bryceson, A.D. Lancet (1983) [Pubmed]
  13. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Davidson, R.N., Croft, S.L., Scott, A., Maini, M., Moody, A.H., Bryceson, A.D. Lancet (1991) [Pubmed]
  14. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Mishra, M., Biswas, U.K., Jha, D.N., Khan, A.B. Lancet (1992) [Pubmed]
  15. Ketoconazole in visceral leishmaniasis. Sundar, S., Kumar, K., Singh, V.P. Lancet (1990) [Pubmed]
  16. 18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B. Ukil, A., Biswas, A., Das, T., Das, P.K. J. Immunol. (2005) [Pubmed]
  17. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation. Basak, S.K., Saha, B., Bhattacharya, A., Roy, S. Eur. J. Immunol. (1992) [Pubmed]
  18. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Mohamed, H.S., Ibrahim, M.E., Miller, E.N., Peacock, C.S., Khalil, E.A., Cordell, H.J., Howson, J.M., El Hassan, A.M., Bereir, R.E., Blackwell, J.M. Genes Immun. (2003) [Pubmed]
  19. Molecular fingerprinting of Leishmania infantum strains following an outbreak of visceral leishmaniasis in central Israel. Nasereddin, A., Baneth, G., Schönian, G., Kanaan, M., Jaffe, C.L. J. Clin. Microbiol. (2005) [Pubmed]
  20. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Mohamed, H.S., Ibrahim, M.E., Miller, E.N., White, J.K., Cordell, H.J., Howson, J.M., Peacock, C.S., Khalil, E.A., El Hassan, A.M., Blackwell, J.M. Eur. J. Hum. Genet. (2004) [Pubmed]
  21. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. Gantt, K.R., Goldman, T.L., McCormick, M.L., Miller, M.A., Jeronimo, S.M., Nascimento, E.T., Britigan, B.E., Wilson, M.E. J. Immunol. (2001) [Pubmed]
  22. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. Carvalho, E.M., Bacellar, O., Brownell, C., Regis, T., Coffman, R.L., Reed, S.G. J. Immunol. (1994) [Pubmed]
  23. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines. Sarkar, K., Das, P.K. J. Immunol. (1997) [Pubmed]
  24. Unresponsive CD4+ T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7-1/CTLA-4 molecular pathway. Gomes, N.A., Barreto-de-Souza, V., Wilson, M.E., DosReis, G.A. J. Infect. Dis. (1998) [Pubmed]
  25. Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon. Manna, P.P., Bharadwaj, D., Bhattacharya, S., Chakrabarti, G., Basu, D., Mallik, K.K., Bandyopadhyay, S. Infect. Immun. (1993) [Pubmed]
  26. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. Ho, J.L., He, S.H., Rios, M.J., Wick, E.A. J. Infect. Dis. (1992) [Pubmed]
  27. Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Junghae, M., Raynes, J.G. Infect. Immun. (2002) [Pubmed]
  28. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. Lehmann, J., Enssle, K.H., Lehmann, I., Emmendörfer, A., Lohmann-Matthes, M.L. J. Interferon Cytokine Res. (2000) [Pubmed]
  29. CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis. Potestio, M., D'Agostino, P., Romano, G.C., Milano, S., Ferlazzo, V., Aquino, A., Di Bella, G., Caruso, R., Gambino, G., Vitale, G., Mansueto, S., Cillari, E. Immunology (2004) [Pubmed]
  30. Experimental visceral leishmaniasis: role of trans-aconitic acid in combined chemotherapy. Kar, S., Kar, K., Bhattacharya, P.K., Ghosh, D.K. Antimicrob. Agents Chemother. (1993) [Pubmed]
  31. Effect of treatment with interferon-gamma alone in visceral leishmaniasis. Sundar, S., Murray, H.W. J. Infect. Dis. (1995) [Pubmed]
  32. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India. Theinert, S.M., Basu, R., Forgber, M., Roy, S., Sundar, S., Walden, P. Infect. Immun. (2005) [Pubmed]
  33. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres. Sánchez-Brunete, J.A., Dea, M.A., Rama, S., Bolás, F., Alunda, J.M., Raposo, R., Méndez, M.T., Torrado-Santiago, S., Torrado, J.J. Antimicrob. Agents Chemother. (2004) [Pubmed]
  34. Identification and characterization of adsorbed serum sialoglycans on Leishmania donovani promastigotes. Chatterjee, M., Chava, A.K., Kohla, G., Pal, S., Merling, A., Hinderlich, S., Unger, U., Strasser, P., Gerwig, G.J., Kamerling, J.P., Vlasak, R., Crocker, P.R., Schauer, R., Schwartz-Albiez, R., Mandal, C. Glycobiology (2003) [Pubmed]
WikiGenes - Universities